Congenital athymia: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Congenital athymia | |||
| image = [[File:Human_thymus_posterior_view.jpg|250px]] | |||
| caption = Posterior view of the human thymus | |||
| synonyms = Thymic aplasia | |||
| specialty = [[Immunology]] | |||
| symptoms = [[Immunodeficiency]], [[recurrent infections]], [[failure to thrive]] | |||
| onset = [[Birth]] | |||
| duration = Lifelong | |||
| causes = Genetic mutations (e.g., [[22q11.2 deletion syndrome]], [[CHARGE syndrome]]) | |||
| risks = Increased susceptibility to infections | |||
| diagnosis = [[Genetic testing]], [[immunophenotyping]] | |||
| differential = [[Severe combined immunodeficiency]], [[DiGeorge syndrome]] | |||
| treatment = [[Thymus transplantation]], [[Hematopoietic stem cell transplantation]] | |||
| prognosis = Variable, dependent on treatment | |||
| frequency = Rare | |||
}} | |||
== Congenital Athymia == | == Congenital Athymia == | ||
[[File:Human_thymus_posterior_view.jpg|thumb|left|Posterior view of the human thymus]] | |||
[[File:Human_thymus_posterior_view.jpg|thumb| | |||
'''Congenital athymia''' is a rare immunodeficiency disorder characterized by the absence of the [[thymus]] gland at birth. The thymus is a critical organ in the development of the [[immune system]], particularly in the maturation of [[T cells]], which are essential for adaptive immunity. | '''Congenital athymia''' is a rare immunodeficiency disorder characterized by the absence of the [[thymus]] gland at birth. The thymus is a critical organ in the development of the [[immune system]], particularly in the maturation of [[T cells]], which are essential for adaptive immunity. | ||
== Pathophysiology == | == Pathophysiology == | ||
In congenital athymia, the thymus fails to develop during embryogenesis. This results in a lack of functional T cells, leading to severe immunodeficiency. Without T cells, the body is unable to mount an effective immune response against infections, making individuals highly susceptible to a wide range of pathogens. | In congenital athymia, the thymus fails to develop during embryogenesis. This results in a lack of functional T cells, leading to severe immunodeficiency. Without T cells, the body is unable to mount an effective immune response against infections, making individuals highly susceptible to a wide range of pathogens. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
Infants with congenital athymia typically present with recurrent infections, failure to thrive, and other signs of immunodeficiency. The absence of the thymus can be confirmed through imaging studies and laboratory tests that show a lack of T cell production. | Infants with congenital athymia typically present with recurrent infections, failure to thrive, and other signs of immunodeficiency. The absence of the thymus can be confirmed through imaging studies and laboratory tests that show a lack of T cell production. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of congenital athymia involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests often reveal low or absent T cell counts. Imaging, such as chest X-rays or MRI, can confirm the absence of the thymus. | Diagnosis of congenital athymia involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests often reveal low or absent T cell counts. Imaging, such as chest X-rays or MRI, can confirm the absence of the thymus. | ||
== Treatment == | == Treatment == | ||
The primary treatment for congenital athymia is [[thymus transplantation]], which can provide the necessary environment for T cell development. Other supportive treatments include prophylactic antibiotics and immunoglobulin replacement therapy to help prevent infections. | The primary treatment for congenital athymia is [[thymus transplantation]], which can provide the necessary environment for T cell development. Other supportive treatments include prophylactic antibiotics and immunoglobulin replacement therapy to help prevent infections. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with congenital athymia has improved with advances in treatment, particularly thymus transplantation. Early diagnosis and intervention are crucial for improving outcomes. | The prognosis for individuals with congenital athymia has improved with advances in treatment, particularly thymus transplantation. Early diagnosis and intervention are crucial for improving outcomes. | ||
== See Also == | |||
== | |||
* [[Thymus]] | * [[Thymus]] | ||
* [[T cell]] | * [[T cell]] | ||
* [[Immunodeficiency]] | * [[Immunodeficiency]] | ||
* [[Thymus transplantation]] | * [[Thymus transplantation]] | ||
{{Immunology}} | {{Immunology}} | ||
{{Congenital disorders}} | {{Congenital disorders}} | ||
[[Category:Immunodeficiency disorders]] | [[Category:Immunodeficiency disorders]] | ||
[[Category:Congenital disorders]] | [[Category:Congenital disorders]] | ||
Latest revision as of 00:15, 6 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Congenital athymia | |
|---|---|
| File:Human thymus posterior view.jpg | |
| Synonyms | Thymic aplasia |
| Pronounce | N/A |
| Specialty | Immunology |
| Symptoms | Immunodeficiency, recurrent infections, failure to thrive |
| Complications | N/A |
| Onset | Birth |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutations (e.g., 22q11.2 deletion syndrome, CHARGE syndrome) |
| Risks | Increased susceptibility to infections |
| Diagnosis | Genetic testing, immunophenotyping |
| Differential diagnosis | Severe combined immunodeficiency, DiGeorge syndrome |
| Prevention | N/A |
| Treatment | Thymus transplantation, Hematopoietic stem cell transplantation |
| Medication | N/A |
| Prognosis | Variable, dependent on treatment |
| Frequency | Rare |
| Deaths | N/A |
Congenital Athymia[edit]
Congenital athymia is a rare immunodeficiency disorder characterized by the absence of the thymus gland at birth. The thymus is a critical organ in the development of the immune system, particularly in the maturation of T cells, which are essential for adaptive immunity.
Pathophysiology[edit]
In congenital athymia, the thymus fails to develop during embryogenesis. This results in a lack of functional T cells, leading to severe immunodeficiency. Without T cells, the body is unable to mount an effective immune response against infections, making individuals highly susceptible to a wide range of pathogens.
Clinical Presentation[edit]
Infants with congenital athymia typically present with recurrent infections, failure to thrive, and other signs of immunodeficiency. The absence of the thymus can be confirmed through imaging studies and laboratory tests that show a lack of T cell production.
Diagnosis[edit]
Diagnosis of congenital athymia involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests often reveal low or absent T cell counts. Imaging, such as chest X-rays or MRI, can confirm the absence of the thymus.
Treatment[edit]
The primary treatment for congenital athymia is thymus transplantation, which can provide the necessary environment for T cell development. Other supportive treatments include prophylactic antibiotics and immunoglobulin replacement therapy to help prevent infections.
Prognosis[edit]
The prognosis for individuals with congenital athymia has improved with advances in treatment, particularly thymus transplantation. Early diagnosis and intervention are crucial for improving outcomes.
See Also[edit]
| Immunology | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This immunology-related article is a stub.
|
| Congenital Disorders | ||||||||
|---|---|---|---|---|---|---|---|---|
This congenital disorder related article is a stub.
|